SCHEMBL14020644

SCHEMBL14020644

CCOC(=O)[C@@]12C[C@H]1/C=C\CCCN(C)C(=O)N1C[C@@H](O)C[C@H]1C(=O)N2

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2837629 0.97 CTSB (0.31) —
SCHEMBL6760157 0.97 CTSB (0.31) —
SCHEMBL2837626 0.97 CTSB (0.31) —
SCHEMBL8245129 0.97 CTSB (0.31) —
SCHEMBL8185437 0.85 ADRB3 (0.31) —
SCHEMBL16628832 0.84 ADRB3 (0.33) —
SCHEMBL16628833 0.84 ADRB3 (0.33) —
SCHEMBL12794554 0.84 MEN1 (0.35) —
SCHEMBL15216165 0.84 CTSB (0.32) —
SCHEMBL10283465 0.84 CTSB (0.32) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080262058-A1 Macrocylic Inhibitors of Hepatitis C Virus JANSSEN SCIENCES IRELAND UC (IE) 2008-10-23 — — US disclosed
Send feedback